Desmoid tumors: who, when and how to treat?

Curr Opin Oncol

Department of Surgical Oncology, Institut Curie, University of Paris, Paris, France.

Published: July 2022

Purpose Of Review: The objective of this article is to summarize new treatment strategies of desmoid tumors.

Recent Findings: Desmoid tumor has an unpredictable evolution that may spontaneously regress or stabilize. A shift toward an initial frontline active surveillance has been acknowledged by experts. Surveillance monitoring should be performed frequently after the diagnosis to avoid missing a significant progression and then spaced in case of stabilization. Treatment is based on significant tumor growth or symptoms. Recent guidelines recommend commencing medical treatment. Kinase inhibitors and cytotoxic agents are the two classes of drugs where studies included progressive desmoid tumors and should be selected to guide medical practice. In a randomized trial, 2 years progression-free survival (PFS) was significantly better in the sorafenib group (81 versus 36% in the placebo group). In another randomized phase 2, 6 months PFS was 83.7% with pazopanib versus 45% with methotrexate and vinblastine. In a retrospective study, including progressive desmoid tumors, methotrexate + vinca alkaloids achieved 75 months median PFS. Cryotherapy is an alternative option in desmoid tumors with compatible locations and tumor sizes. Following medical treatment or cryotherapy failure, superficial sites represent the best indications for surgery in cases of continuous progression. In the event of a contra-indication or failure of medical treatment, in locations where surgery would be mutilating and incomplete, radiotherapy is an effective option.

Summary: Active surveillance with planned imaging has become the first-line management in desmoid tumor.

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000854DOI Listing

Publication Analysis

Top Keywords

desmoid tumors
16
medical treatment
12
desmoid tumor
8
active surveillance
8
progressive desmoid
8
desmoid
7
treatment
5
tumors treat?
4
treat? purpose
4
purpose review
4

Similar Publications

Article Synopsis
  • Desmoid tumours are rare benign growths that can aggressively invade surrounding tissues, especially near nerves and blood vessels, making them difficult to treat.
  • Their exact cause is unknown, but they are more common in females and may be linked to factors like trauma, surgery, or inflammation, suggesting possible genetic or hormonal influences.
  • A case study highlights a 34-year-old woman who developed a desmoid tumour in her neck after neck surgery; despite surgical removal, the tumour recurred, necessitating a second operation for complete treatment.
View Article and Find Full Text PDF

Familial adenomatous polyposis family with clustering of psychiatric disorders.

Jpn J Clin Oncol

January 2025

Department of Clinical Oncology, Graduate School of Medicine, Akita University, Hondo 1-1-1, Akita, 010-8543, Japan.

Article Synopsis
  • Familial adenomatous polyposis (FAP) is an inherited disorder caused by mutations in the APC gene, leading to colorectal polyps and other health issues.
  • This condition can also cause extracolonic manifestations like desmoid tumors and various mental disorders in affected families.
  • A case study highlights the importance of mental health care in genetic counseling, as a family with FAP showed connections between the disorder and mental health issues, including autism spectrum disorder and intellectual disabilities.
View Article and Find Full Text PDF

Breast desmoid tumour is a rare type of benign breast disease that presents like malignancy. Current guidelines are based on limited evidence derived from case reports and small case series and recommend resection with microscopically-negative margin (R0). There is a high risk of recurrence despite negative surgical margins.

View Article and Find Full Text PDF

Background: Desmoid-type fibromatosis of the breast is a rare, benign, but locally aggressive tumor that typically affects women. Its presentation in male patients is exceedingly rare, and even more so following a cosmetic procedure such as liposuction. This case report describes a unique presentation of breast fibromatosis in a male patient, who developed the condition after undergoing liposuction for cosmetic purposes to define the pectoral area.

View Article and Find Full Text PDF

Aggressive fibromatosis is a rare, benign proliferative disease with unknown aetiology and high recurrence rate. To date, there are only eight reported cases affecting the larynx. Four were managed with total laryngectomy, whilst spontaneous regression happened in one case.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!